GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Take Solutions Ltd (NSE:TAKE) » Definitions » LT-Debt-to-Total-Asset

Take Solutions (NSE:TAKE) LT-Debt-to-Total-Asset : 0.00 (As of Dec. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Take Solutions LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Take Solutions's long-term debt to total assests ratio for the quarter that ended in Dec. 2024 was 0.00.

Take Solutions's long-term debt to total assets ratio stayed the same from Dec. 2023 (0.00) to Dec. 2024 (0.00).


Take Solutions LT-Debt-to-Total-Asset Historical Data

The historical data trend for Take Solutions's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Take Solutions LT-Debt-to-Total-Asset Chart

Take Solutions Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.09 0.09 0.02 0.06 0.08

Take Solutions Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.08 - - -

Take Solutions LT-Debt-to-Total-Asset Calculation

Take Solutions's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (A: Mar. 2024 )=Long-Term Debt & Capital Lease Obligation (A: Mar. 2024 )/Total Assets (A: Mar. 2024 )
=65.79/881.05
=0.07

Take Solutions's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (Q: Dec. 2024 )=Long-Term Debt & Capital Lease Obligation (Q: Dec. 2024 )/Total Assets (Q: Dec. 2024 )
=0/0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Take Solutions  (NSE:TAKE) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.


Take Solutions LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Take Solutions's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Take Solutions Business Description

Traded in Other Exchanges
Address
No.56, Dr. Radhakrishnan Salai, 4th Floor, Ragas Building, Mylapore, Chennai, TN, IND, 600004
Take Solutions Ltd is a technology-driven clinical research organization supporting pharma, biotech, and devices companies. It offers a combination of full-service Clinical Research, Generics Development, Data Sciences, Regulatory Affairs, and Pharmacovigilance and Safety services. The company operates in a single segment; Life Sciences and Support Services.

Take Solutions Headlines

No Headlines